Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

800px-eli_lilly_corporate_center_indianapolis_indiana_usa_1

Eli Lilly COVID-19 antibody therapy trial paused over safety concerns

October 14, 2020 Research and Development COVID, Eli Lilly, coronavirus

Eli Lilly has stopped enrolling volunteers in clinical trials of its antibody treatment for the novel coronavirus over safety concerns.  …
News
pxfuel

British man suffers from permanent hearing damage after contracting COVID-19

October 14, 2020 Research and Development COVID-19, pharma

A 45-year-old man in the UK has been left with permanent hearing damage after being infected with the novel coronavirus, …
News
shutterstock_512649

Johnson & Johnson to contribute a further $1 billion to US opioid settlement

October 14, 2020 Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma

Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 14, 2020 Research and Development COVID-19, coronavirus, covid news, pandemic, weekly roundup

The COVID-19 news this week focuses on FDA authorisations, with Eli Lilly seeking Emergency Use Authorization (EUA) from the FDA …
News

J&J halts COVID-19 vaccine study following unidentified participant illness

October 13, 2020 Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma

Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
News
shutterstock_3

University of Glasgow research details promising precision medicine approach in pancreatic cancer

October 12, 2020 Research and Development, Sales and Marketing Cancer, Precision Medicine

Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients …
News

Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin

October 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Eggan, appointments

BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He …
Appointment
shutterstock_273326141

Takeda and Arrowhead Pharma join forces in $1m rare liver disease drug development pact

October 9, 2020 Medical Communications, Research and Development Arrowhead, Takeda, pharma

A new partnership has been struck between Takeda and Arrowhead Pharmaceuticals, with both companies coming together to co-develop and license …
News
david_nicholson

Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors

October 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment

Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …
Appointment
nhs-westminster

COVID-19 has caused over three times more deaths than flu or pneumonia in England and Wales

October 8, 2020 Medical Communications, Research and Development COVID-19, UK, flu

Newly released data has revealed that COVID-19 has resulted in many more deaths than influenza or pneumonia in England and …
News
woman-smartphone-girl-technology

GSK tells UK staff to turn off NHS COVID-19 tracking app while at work

October 7, 2020 Research and Development COVID, GSK, covid app

GlaxoSmithKline has told its employees to turn off the new NHS coronavirus tracking app at work as it could be …
News
26190151124_fa4ae08b82_b

Johnson & Johnson to spend over $100m to settle 1,000 talc powder lawsuits

October 7, 2020 Research and Development

Johnson & Johnson have agreed to pay over $100 million to settle more than 1,000 lawsuits that blame the company’s …
News
glenmark

FDA greenlights Glenmark’s generic version of Biogen’s Tecfidera in relapsing multiple sclerosis

October 7, 2020 Research and Development, Sales and Marketing Biogen, Glenmark, generic, multiple sclerosis

Glenmark Pharma will be celebrating after it secured FDA approval in the US to market dimethyl fumarate, a generic version …
News
injection-2248377_960_720

EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine

October 7, 2020 Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …
News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 7, 2020 Research and Development COVID, COVID-19, corornavirus

The coronavirus news this week focuses on treatments, with Enlivex Therapeutics releasing positive data for its therapy Allocetra as a …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026